Fig. 4
From: CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker
Go and ImmuneSigDB enrichment analysis of CD44 in indicated tumor types. A Go enrichment results of PAAD, GBM, BRCA, and PRAD. B ImmuneSigDB enrichment results of PAAD, GBM, BRCA, and PRAD. Values of p < 0.05 and results higher than 5 were considered and displayed